These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22996185)

  • 1. Comment on: Inzucchi et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379.
    Giaccari A; Giorda CB; Riccardi G; De Micheli A; Bruno G; Monge L; Frontoni S
    Diabetes Care; 2012 Oct; 35(10):e71; author reply e72-3. PubMed ID: 22996185
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Inzucchi et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379.
    Rodbard HW; Jellinger PS
    Diabetes Care; 2012 Oct; 35(10):e70; author reply e72-3. PubMed ID: 22996184
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR; ;
    Diabetes Care; 2012 Jun; 35(6):1364-79. PubMed ID: 22517736
    [No Abstract]   [Full Text] [Related]  

  • 4. American diabetes association-European association for the study of diabetes position statement: due diligence was conducted.
    Cefalu WT
    Diabetes Care; 2012 Jun; 35(6):1201-3. PubMed ID: 22619286
    [No Abstract]   [Full Text] [Related]  

  • 5. A practice-based approach to the 2012 position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
    Schwartz SS
    Curr Med Res Opin; 2013 Jul; 29(7):793-9. PubMed ID: 23614630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    McCormack JP; Martin SA; Newman DH
    Diabetes Care; 2015 Sep; 38(9):e141-2. PubMed ID: 26294778
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    Landman GW; Kleefstra N; Houweling ST
    Diabetes Care; 2015 Aug; 38(8):e127. PubMed ID: 26207067
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    Mazzucchelli C; Bordone C; Maggi D; Cordera R
    Diabetes Care; 2015 Aug; 38(8):e125-6. PubMed ID: 26207066
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    Herman WH
    Diabetes Care; 2015 Sep; 38(9):e143. PubMed ID: 26294779
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    Inzucchi SE; Matthews DR;
    Diabetes Care; 2015 Aug; 38(8):e128-9. PubMed ID: 26207068
    [No Abstract]   [Full Text] [Related]  

  • 11. Do published ADA studies support the ADA-EASD position statement for the management of hyperglycaemia in type 2 diabetics?
    Rimareix F; Bauduceau B
    Ann Endocrinol (Paris); 2013 Jul; 74(3):207-10. PubMed ID: 23747137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Davies MJ; D'Alessio DA; Fradkin J; Kernan WN; Mathieu C; Mingrone G; Rossing P; Tsapas A; Wexler DJ; Buse JB
    Diabetes Care; 2018 Dec; 41(12):2669-2701. PubMed ID: 30291106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetologia; 2012 Jun; 55(6):1577-96. PubMed ID: 22526604
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of hyperglycaemia of type 2 diabetes. Paradigm change according to the ADA-EASD consensus report 2018].
    Scheen AJ; Paquot N
    Rev Med Liege; 2018 Dec; 73(12):629-633. PubMed ID: 30570234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721.
    Cryer PE
    Diabetologia; 2007 Jan; 50(1):222-4; discussion 225-30; author reply 231-3. PubMed ID: 17047916
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of patients with type 2 diabetes at cardiovascular and renal risk : ESC versus ADA-EASD].
    Scheen AJ; Paquot N
    Rev Med Suisse; 2020 Aug; 16(703):1478-1482. PubMed ID: 32852167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the management of type 2 diabetes: is ADA and EASD consensus more clinically relevant than the IDF recommendations?
    Czupryniak L
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S22-5. PubMed ID: 20115928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-centred care in type 2 diabetes mellitus - Key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report.
    Fritzen K; Stautner C; Schnell O
    Diabetes Res Clin Pract; 2019 Dec; 158():107897. PubMed ID: 31672502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Davies MJ; Aroda VR; Collins BS; Gabbay RA; Green J; Maruthur NM; Rosas SE; Del Prato S; Mathieu C; Mingrone G; Rossing P; Tankova T; Tsapas A; Buse JB
    Diabetes Care; 2022 Nov; 45(11):2753-2786. PubMed ID: 36148880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: Raz et al. Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. Diabetes care 2013;36:1779-1788.
    Giugliano D; Esposito K
    Diabetes Care; 2013 Nov; 36(11):e192. PubMed ID: 24159187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.